Apatite-forming ability of a zirconia/alumina nano-composite induced by chemical treatment

Induction of an apatite-forming ability on a nano-composite of a ceria-stabilized tetragonal zirconia polycrystals (Ce-TZP) and alumina (Al2O3) polycrystals via chemical treatment with aqueous solutions of H3PO4, H2SO4, HCl, or NaOH has been investigated. The Ce-TZP/Al2O3 composite is attractive as a load-bearing bone substitute because of its mechanical properties. The chemical treatments produced Zr-OH surface functional groups, which are known to be effective for apatite nucleation in a body environment. The composite, after chemical treatment, was shown to form a bonelike apatite layer when immersed in a simulated body fluid containing ion concentrations nearly equal to those in human blood plasma. This implies that it may form apatite in the living body and bond to living bone through the apatite layer. This type of bioactive Ce-TZP/Al2O3 composite is therefore expected to be useful as a bone substitute, even under load-bearing conditions.     

Phase stability after aging and its influence on pin-on-disk wear properties of Ce-TZP/Al2O3 nanocomposite and conventional Y-TZP

Recently zirconia/alumina composites have been examined by many researchers as the new generation of bearing materials in total joint replacements. In this study, the phase stability of a Ce-TZP/Al(2)O(3) nanocomposite and conventional Y-TZP after aging, and its influence on wear resistance, were investigated. Very slight phase transformation was observed in both types of ceramics 18 months after the implantation of Ce-TZP/Al(2)O(3) or Y-TZP samples into rabbit tibiae. However, Y-TZP showed marked phase transformation (approximately 80%) after aging in an autoclave (121 degrees C) for 190 h or in physiological saline at 62 degrees C for 18 months, whereas the new composite remained almost resistant to degradation. According to the results of self-pairing pin-on-disk wear tests using ceramic specimens with or without autoclave aging, the wear factor was almost the same between Ce-TZP/Al(2)O(3) samples with and without aging (6.74 +/- 0.36 x 10(-8) and 6.04 +/- 0.95 x 10(-8) mm(3)/Nm, respectively). In contrast, although non-aged Y-TZP had the lowest wear factor (4.88 +/- 0.51 x 10(-8) mm(3)/Nm) of all specimens tested, aged Y-TZP showed 10-fold greater wear than nonaged Y-TZP. The present study suggests that Ce-TZP/Al(2)O(3) nanocomposite has much greater phase stability than Y-TZP, and that its wear properties are not influenced by aging.     

Biaxial flexure strength and low temperature degradation of Ce-TZP/Al2O3 nanocomposite and Y-TZP as dental restoratives

The purpose of the present study was to evaluate the mechanical durability of a zirconia/alumina nanocomposite stabilized with cerium oxide (Ce-TZP/Al(2)O(3) nanocomposite) in comparison to yttria-stabilized tetragonal zirconia polycrystals (Y-TZP) and discuss its application on ceramic dental restorations. The disk-shaped specimens of both materials were stored in physiological saline solution at 80 degrees C for 30 days, in 4% acetic acid at 80 degrees C for 30 days, and in an autoclave at 121 degrees C for 10 days. Before and after storage, specimens were subjected to the biaxial flexure test and to the determination of the monoclinic zirconia content. After autoclaving, Y-TZP showed remarkable increasing of the content of monoclinic zirconia: 0.3 vol % before and 49.9 vol % after, and slight decreasing of biaxial flexure strength: 1046 MPa before and 892 MPa after; whereas Ce-TZP/Al(2)O(3) nanocomposite showed no significant difference in the monoclinic content (4.8-5.5 vol %) and the biaxial flexure strength (1371-1422 MPa) after storage in any conditions. It is concluded that, compared to Y-TZP, the Ce-TZP/Al(2)O(3) nanocomposite has a high biaxial flexure strength along with a satisfactory durability in terms of low-temperature aging degradation in above conditions. This study indicates that the Ce-TZP/Al(2)O(3) nanocomposite demonstrates excellent mechanical durability for dental restorations such as all-ceramic bridges.     

Ce-TZP/Al2O3 nanocomposite as a bearing material in total joint replacement

The objectives of this study were to investigate the biocompatibility, phase stability, and wear properties of a newly developed Ce-TZP/Al(2)O(3) nanocomposite, as compared to conventional ceramics, and to determine whether the new composite could be used as a bearing material in total joint prostheses. In tests of mechanical properties, this composite showed significantly higher toughness than conventional Y-TZP. For biocompatibility tests, cylindrical specimens of both the Ce-TZP/Al(2)O(3) nanocomposite and monolithic alumina were implanted into the paraspinal muscles of male Wistar rats. The tissue reactions were almost the same, and at 24 weeks after implantation, thin fibrous capsules with almost no inflammation were observed around both of them. There were no significant differences in membrane thickness between the two ceramics. After hydrothermal treatment in 121 degrees C vapor for 18 h, the new composite showed complete resistance to aging degradation, whereas Y-TZP showed a phase transformation of 25.3 vol% (initial 0.4%) to the monoclinic form. According to the results of pin-on-disk tests, the wear rates of Ce-TZP/Al(2)O(3) nanocomposite and alumina were 0.55 +/- 0.04 x 10(-7) and 2.12 +/- 0.37 x 10(-7)mm(3)/Nm, respectively. The results of this study suggest that the Ce-TZP/Al(2)O(3) nanocomposite is a promising alternative ceramic component for total joint replacement.     

Low-temperature degradation of different zirconia ceramics for dental applications

The aim of this investigation was to determine the influence of simulated ageing on the tetragonal-to-monoclinic phase transformation and on the flexural strength of a 3Y-TZP ceramic, compared to alumina toughened zirconia (ATZ) and ceria-stabilized zirconia (12Ce-TZP). Standardized disc specimens of each material were hydrothermally aged in steam at 134°C and 3bar for 0, 16, 32, 64 or 128h. The phase transformation was determined by X-ray diffraction (XRD) and atomic force microscopy. Scanning electron microscopy was performed to estimate the depth of the transformation zone. The flexural strength was investigated in a biaxial flexural test. XRD revealed a significant increase in the monoclinic phase content for 3Y-TZP and ATZ due to ageing, although this increase was less pronounced for ATZ. In contrast, the monoclinic phase content of 12Ce-TZP was not influenced. For 3Y-TZP and ATZ, a transformation zone was found of which the depth linearly correlated with ageing time, while for 12Ce-TZP no transformation zone could be observed. Changes in flexural strength after ageing were heterogeneous: while 3Y-TZP showed a significant decrease in strength - from 1740 to 1169 MPa - with ATZ there was a considerable increase - from 1093 to 1378 MPa. The flexural strength of 12Ce-TZP remained unaffected at the low level of about 500 MPa. These results indicate that both alumina and ceria, as stabilizing oxides, reduce the susceptibility of zirconia to hydrothermal degradation; the alternative use of these oxides may enhance the clinical long-term stability of dental zirconia restorations.     

Fracture toughness, strength and slow crack growth in a ceria stabilized zirconia-alumina nanocomposite for medical applications

Mechanical properties and slow crack growth (SCG) behavior of a 10Ce-TZP/Al2O3 nanocomposite currently developed as a biomaterial are considered. Fracture toughness is determined for sharp, long (double torsion) and short (indentation) cracks and a good agreement is found between the two types of cracks. The main toughening mechanism in the nanocomposite is the tetragonal to monoclinic phase transformation of the ceria-stabilized zirconia (Ce-TZP) phase. Transformation at the surface of ground specimens leads to surface compressive induced stresses and an increase in strength. Crack velocity curves (V-K(I) curves) are obtained under static and cyclic fatigue using the double torsion method. The static V-K(I) curve in air reveals the three stages characteristic of stress corrosion with a threshold K(I0) approximately 4.5 MPa m(1/2) and a fracture toughness of 8.8 MPa m(1/2) significantly higher than those of currently used inert bioceramics (i.e., alumina and Y-TZP). A crack growth accelerating effect is shown under cyclic loading, correlated with a decrease in the threshold. However, the cyclic fatigue threshold (4 MPa m(1/2)) still stands above that of current biomedical grade alumina and zirconia.     

In vitro characterisation of zirconia coated by bioactive glass

An in vitro evaluation of a biomedical device, which combines the mechanical properties of zirconia substrates with the bioactivity of two different glass layers (AP40 and RKKP), was performed. In this work, data on different kinds of analysis were reported both on as-sintered zirconia samples and on RKKP- and AP40-coated zirconia substrates. Structure, composition and morphology of the apatite layer growth on the coated samples after 30 days of soaking in an acellular simulated body fluid, serum protein adsorption, fibroblasts and human osteoblast-like cells adhesion, growth, morphology and biochemical aspects were studied. Results of soaking test in SBF, revealed the growth of an apatite layer on the surface of the glass-coated samples. Proteins adsorbed to the materials were analysed by sodium dodecyl sulphate-polyacrylamide gel electrophoresis and results evidenced that the two glass-coated materials bound a higher amount of total protein than did the zirconia substrate. Fibroblasts and osteoblast-like cells cultured on RKKP- and AP40-coated zirconia showed a higher proliferation rate, leading to confluent cultures with higher cell density and a generally better expression of osteoblast alkaline phosphatase activity in comparison with zirconia substrate. In conclusion, our results indicate that the surface chemical characteristics of the two glass coatings AP40 and RKKP, with no great differences between them, substantially enhance zirconia integration with bone cells at least in vitro. This effect may be of significance in the stability of glass-coated zirconia orthopaedic and dental implants.     

In vitro bioactivity and phase stability of plasma-sprayed nanostructured 3Y-TZP coatings

In this work, plasma-sprayed nanostructured zirconia coatings stabilized with 3 mol.% yttria (3Y-TZP) were deposited on Ti substrates. The microstructure and phase composition of coatings were characterized using scanning electron microscopy and X-ray diffraction. The in vitro bioactivity of coatings was evaluated by examining the formation of bone-like apatite on its surface in simulated body fluid. MG63 cell lines were cultured on the coating to investigate its cytocompatibility. The crystalline phase of the as-sprayed coating was tetragonal zirconia, and no monoclinic zirconia was detected. The size of the grains on the as-sprayed coating surface was less than 100 nm. The apatite could precipitate on the surface of the coating immersed in simulated body fluid for 28 days while no apatite was formed on the surface of 3Y-TZP ceramic control, indicating that the bioactivity of the coating is superior to the ceramic with the same composition. It also revealed that the polished coating whose nanostructural outmost layer was removed was bioinert, implying the significance of the nanosized grains for its bioactivity. MG63 cells could adhere, grow and proliferate well on the coating surface, indicating that the coating had good cytocompatibility. Phase stability of plasma-sprayed 3Y-TZP coating was evaluated under hydrothermal conditions at 134 °C. It revealed that the plasma-sprayed nanostructured zirconia coating was more sensitive to aging than that of zirconia ceramics.     

Fabrication and in vitro characterization of magnetic hydroxycarbonate apatite coatings with hierarchically porous structures

Hydroxycarbonate apatite/Fe(3)O(4) composite coatings (MHACs) with hierarchically porous structures were fabricated by electrophoretic deposition of CaCO(3)/Fe(3)O(4) particles on Ti6Al4V substrates followed by treatment with phosphate buffer solution (PBS) at 37 degrees C. The effects of Fe(3)O(4) on the conversion rate of calcium carbonate to hydroxycarbonate apatite and the porous structures and in vitro bioactivity of MHACs were investigated. After soaking CaCO(3)/Fe(3)O(4) coatings in PBS, hydroxycarbonate apatite nucleates heterogeneously on the surfaces of CaCO(3)/Fe(3)O(4) particles and forms a plate-like structure. Fe(3)O(4) increases the velocity of nucleus formation of hydroxycarbonate apatite. After soaking for 1day, the percentage of unreacted calcium carbonate for MHACs is approximately 9.1%, lower than the approximately 41.0% for hydroxycarbonate apatite coatings (HCACs). As the CaCO(3)/Fe(3)O(4) coatings are converted to MHACs, macropores with a pore size of approximately 4mum on the coatings and mesopores with a pore size of approximately 3.9nm within the hydroxycarbonate apatite plates are formed. The mesopores remain in the MHACs after treatment with PBS for 9 days, while they disappear in the HCACs. Simulated body fluid immersion tests reveal that Fe(3)O(4) improves the in vitro bioactivity of biocoatings. The amount of bone-like apatite precipitated on the surfaces of MHACs is greater than that on the surfaces of HCACs.     

Microstructure,bioactivity and osteoblast behavior of monoclinic zirconia coating with nanostructured surface

A monoclinic zirconia coating with a nanostructural surface was prepared on the Ti–6Al–4V substrate by an atmospheric plasma-spraying technique, and its microstructure and composition, as well as mechanical and biological properties, were investigated to explore potential application as a bioactive coating on bone implants. X-ray diffraction, transmission electron microscopy, scanning electron microscopy and Raman spectroscopy revealed that the zirconia coating was composed of monoclinic zirconia which was stable at low temperature, and its surface consists of nano-size grains 30–50 nm in size. The bond strength between the coating and the Ti–6Al–4V substrate was 48.4 ± 6.1 MPa, which is higher than that of plasma-sprayed HA coatings. Hydrothermal experiments indicated that the coating was stable in a water environment and the phase composition and Vickers hardness were independent of the hydrothermal treatment time. Bone-like apatite is observed to precipitate on the surface of the coating after soaking in simulated body fluid for 6 days, indicating excellent bioactivity in vitro. The nanostructured surface composed of monoclinic zirconia is believed to be crucial to its bioactivity. Morphological observation and the cell proliferation test demonstrated that osteoblast-like MG63 cells could attach to, adhere to and proliferate well on the surface of the monoclinic zirconia coating, suggesting possible applications in hard tissue replacements.     

Fabrication and characteristics of bioactive sodium titanate/titania graded film on NiTi shape memory alloy

A bioactive sodium titanate/titania graded film was formed in situ on NiTi shape memory alloy (SMA) by oxidizing in H(2)O(2) solution and subsequent NaOH treatment and characterized by scanning electron microscopy, Raman spectroscopy, X-ray diffraction, Fourier transform infrared spectroscopy, and X-ray photoelectron spectroscopy (XPS). The bioactivity of the film was investigated using a simulated body fluid (SBF) soaking test. A titania (TiO(2)) layer was first found on NiTi substrate after oxidized in H(2)O(2) solution, and then a porous sodium titanate (Na(2)TiO(3))/titania film with many Ti--OH groups and a trace of Ni(2)O(3) was formed by the reaction of partial TiO(2) phase with NaOH solution. After immersion in SBF for 12 h, apatite was observed to nucleate and grow on the film. With longer soaking time, more apatite appeared on its surface but our control experiments didn't reveal any apatite formation on the chemically polished NiTi SMA, which indicates the bioactivity of NiTi implants could be improved by the formation of the bioactive film. Moreover, XPS depth profiles of O, Ni, Ti, and Na show the bioactive film possesses a smooth graded interface structure to NiTi substrate, which is in favor of sufficient mechanical stability of apatite layer by subsequent deposition in SBF.     

Bioactivity and cytocompatibility of zirconia (ZrO(2)) films fabricated by cathodic arc deposition

Zirconium oxide thin films were fabricated on silicon wafers using a filtered cathodic arc system in concert with oxygen plasma. The structure and phase composition of the zirconium oxide thin films were characterized by atomic force microscopy (AFM), X-ray diffraction (XRD), Rutherford backscattering spectrometry (RBS), and transmission electron microscopy (TEM). The bioactivity was assessed by investigating the formation of apatite on the film surface after soaking in simulated body fluids. Bone marrow mesenchymal stem cells (BMMSC) were used to further evaluate the cytocompatibility of the materials. The results indicate that the films are composed of stoichiometric ZrO(2) and the composition is quite uniform throughout the thickness. Bone-like apatite can be formed on the surface of the ZrO(2) thin film in our SBF immersion experiments, suggesting that the surface is bioactive. The outermost layer of the ZrO(2) thin film comprises nano-sized particles that can be identified by AFM images taken on the thin film surface and TEM micrographs obtained from the interface between the ZrO(2) thin film and apatite layer. The nanostructured surface is believed to be the key factor that apatite is induced to precipitate on the surface. Bone marrow mesenchymal stem cells are observed to grow and proliferate in good states on the film surface. Our results show that ZrO(2) thin films fabricated by cathodic arc deposition exhibit favorable bioactivity and cytocompatibility.     

Improvement of surface bioactivity on titanium by water and hydrogen plasma immersion ion implantation

We have investigated the surface bioactivity of titanium after water and hydrogen plasma immersion ion implantation. Plasma immersion ion implantation (PIII) excels in the surface treatment of components possessing a complicated shape such as medical implants. In addition, water and hydrogen PIII has been extensively studied as a method to fabricate silicon-on-insulator (SOI) substrates in the semiconductor industry and so it is relatively straightforward to transfer the technology to the biomedical field. In our investigation, water and hydrogen were plasma-implanted into titanium sequentially. Our objective is that water PIII introduces near-surface damages that trap hydrogen implanted in the subsequent step to improve the surface bioactivity while the desirable bulk properties of the materials are not compromised. Ti-OH functional groups can be detected on the (H(2)O+H(2))-implanted titanium surface by X-ray photoelectron spectroscopy (XPS) and Fourier transform infrared (FTIR) spectroscopy. After incubation in simulated body fluids (SBF) for cytocompatibililty evaluation in vitro, bone-like hydroxyapatite was found to precipitate on the (H(2)O+H(2)) implanted samples while no apatite was found on titanium samples plasma implanted with water or hydrogen alone. Human osteoblast cells were cultured on the (H(2)O+H(2))-implanted titanium surface and they exhibited good adhesion and growth. Our results suggest a practical means to improve the surface bioactivity and cytocompatibility of medical implants made of titanium.     

Coatings on zirconia for medical applications

In order to combine the mechanical properties of a high-strength inert ceramic (yttria-stabilised zirconia, ZrO2-3%Y2O3, defined as zirconia in the text) with the specific properties of bioactive materials, some zirconia samples were coated by two bioactive phosphosilicate glasses and glass-ceramics: RKKP and AP40. Coatings of about 200-300 microm thickness were prepared by a simple and low-cost firing method. They were characterised by optical and scanning electron microscopy (SEM) and compositional analysis (EDS). The adhesion of the coatings on zirconia was tested by shear tests. Vickers indentations at the coating/zirconia interface were performed in order to observe the crack propagation path. The reactivity of glasses and glass-ceramics coatings towards a simulated body fluid (SBF), having the same ion concentration as that of human plasma, was evaluated and compared to that of the bulk glass and glass-ceramics, by examining the morphology of the reaction layer formed on the surface of the coated zirconia after one month of soaking in the SBF at 37 degrees C.     

Fabrication of hydroxycarbonate apatite coatings with hierarchically porous structures

Hierarchically porous hydroxycarbonate apatite is known to have a high bioactivity to regenerate bone, but its application in bone graft substitutes has been restricted due to its poor mechanical properties. This drawback has been addressed by (i) depositing calcium carbonate coatings on Ti6Al4V substrates by electrophoresis; and (ii) converting the coatings to hydroxycarbonate apatite coatings with hierarchically porous structures by treatment with a phosphate buffer solution (PBS). After soaking calcium carbonate coatings in PBS for 1 day, calcium-deficient hydroxycarbonate apatite nanocrystals are deposited on the surfaces of calcium carbonate particles via a dissolution-precipitation reaction. The aggregation of the nanocrystals produces plate-like hydroxycarbonate apatite. Mesopores with a pore size of approximately 3.8nm and macropores or apertures with an aperture size of approximately 1 microm are formed within and among the plates, respectively. After soaking for 9 days, the pore size of mesopores decreases and the mesopores disappear partly due to the crystal growth of hydroxycarbonate apatite. Simulated body fluid immersion tests reveal that the good in vitro bioactivity of hydroxycarbonate apatite coatings is attributed to the calcium deficiencies in apatite lattice and the hierarchically porous structures.     

Laminated and functionally graded hydroxyapatite/yttria stabilized tetragonal zirconia composites fabricated by spark plasma sintering

Hydroxyapatite (HA) ceramics have been conventionally strengthened and toughened in the form of composites and coatings. New microstructural designs and processing methodologies are still needed for the improvement of the mechanical properties of HA-based ceramics. This study was to prepare laminated and functionally graded HA/yttria stabilized tetragonal zirconia (Y-TZP) composites by the relatively new process of spark plasma sintering (SPS). The microstructure and the mechanical properties of the laminated and functionally graded composites were studied for possible orthopedic applications. It was found that the laminated and functionally graded HA/Y-TZP composites could be densified at 1200 degrees C within 5 min by the SPS process and the average HA grain size in the composite layers was reduced by half due to the well-dispersed Y-TZP second phase. The HA phase in the composite layers was stable up to 1200 degrees C and the Y-TZP second phase remained the tetragonal zirconia (t-ZrO(2)) phase after being processed at the highest temperature of 1250 degrees C. The laminated and functionally graded HA/Y-TZP composites exhibited much improved mechanical properties compared with the pure HA ceramics; the bending strength of the composites reached about 200 MPa, double the strength of the pure HA ceramics.     

In vitro lifetime of dental ceramics under cyclic loading in water

All-ceramic dental restorations exhibit enhanced esthetics and biocompatibility as compared to traditional metal-based prosthesis. However, long-term fatigue and subcritical crack growth in the presence of water and cyclic loading can decrease the strength of ceramic components over time. We investigated the cyclic fatigue in water of three dental materials currently used as frameworks in all-ceramic restorations: a 3 mol%-yttria partially stabilized zirconia (3Y-TZP, Cercon, Degudent GmbH), a Al(2)O(3)-ZrO(2)-Glass composite (Inceram-Zirconia, Vita Zahnfabrik GmbH) and a Li(2)O.2SiO(2) glass ceramic (Empress 2, Ivoclar Vivadent AG). Fatigue and fast fracture tests were performed to determine the Weibull distribution of lifetime and initial mechanical strength for each framework component. In spite of its noticeable susceptibility to fatigue in water, the 3Y-TZP material was found to be particularly suitable for the preparation of posterior all-ceramic bridges due to its high initial mechanical strength. Guidelines are provided for the selection of materials and the design of all-ceramic posterior bridges exhibiting lifetime longer than 20 years under severe wet and cyclic loading conditions.     

Biological glass coating on ceramic materials: in vitro evaluation using primary osteoblast cultures from healthy and osteopenic rat bone

ZrO2 and Al2O3 substrates were successfully coated by a double layer of a silica-based glass named RKKP, using a low-cost firing technique. RKKP is a glass well known for its bioactivity; therefore, a RKKP coating on Al2O3 or ZrO2, allows to combine the excellent mechanical properties of these strong ceramic substrates with its bioactivity. ZrO2 samples were easily coated using a double layer of RKKP by a simple enamelling technique. To accommodate the thermal expansion coefficient mismatch between Al2O3 and RK K P, this substrate was coated using a multilayered composite approach. All of the coatings were characterised from a morphological and compositional point of view, and an extensive biological evaluation was performed using fresh rat osteoblasts. Osteoblast primary cultures were derived from the trabecular bone of femoral condyles harvested from intact (NB) and osteopenic (OB) rats. After characterisation of their phenotype, osteoblasts were seeded on material samples of ZrO2 or Al2O3 coated with RKKP, and cultured for 7 days. Cell proliferation (MTT test) and cell differentiation (alkaline phosphatase activity) were evaluated at the end of the experiment, to assess osteoblast behaviour in the presence of biomaterials and determine if the results were related to the host bone quality. Results of both materials showed a good level of biocompatibility. In particular, MTT significant higher values were detected in NB cultures on ZrO2-RKKP samples; ALP activity significantly increased in NB cultures on Al2O3-RKKP and in OB cultures on both coated samples.     

In vitro evaluation of the mutagenic and carcinogenic power of high purity zirconia ceramic

Tetragonal zirconia polycrystal (TZP) is a new interesting ceramic for the manufacture of medical devices. Its wide use in orthopedic and odontoiatric implants was limited till now by the high chemical and radiochemical impurities of the raw materials. Purification processes now available allow to obtain high purity ceramic grade powders suitable for TZP ceramics manufacture, even if their possible mutagenic and transforming effects are still unclear. The aim of this work is to study in vitro the mutagenic and oncogenic effects of a new zirconia ceramic stabilized by yttria (Y-TZP). This ceramic was sintered from high purity powders obtained by a process developed under a project carried out within the Brite EuRam programme. For comparison, ceramics made from unpurified zirconia powder were also tested. Fibroblasts irradiated by a linear accelerator were used as positive control. The results obtained show that Y-TZP ceramic does not elicit either mutagenic or transforming effect on C3H/10T(1/2) (10T(1/2)) cells and demonstrate that ceramic from high purity powders can be considered suitable for biomedical applications from the point of view of the effects of its radioactive impurity content.     

On the kinetics and impact of tetragonal to monoclinic transformation in an alumina/zirconia composite for arthroplasty applications

Latest trends in load-bearing materials for arthroplastic applications involve the development of highly fracture resistant alumina/zirconia composites, as an alternative choice to alumina and zirconia monolithic ceramics. Composite materials are designed from both chemical and microstructural viewpoints in order to prevent environmental degradation and fracture events in vivo, whose shadow yet hampers the full exploitation of ceramic materials in the field of arthroplasty. The aim of this paper is to evaluate the resistance to environmental degradation in an alumina/zirconia composite (Biolox Delta^®), which represents a primary candidate for hip and knee joint applications. Our approach consists first in the experimental determination of an activation energy value for environmentally driven tetragonal to monoclinic (t–m, henceforth) polymorphic transformation in the zirconia phase of the material; then, based on such an experimental value, a prediction is given for the long-term in vivo environmental resistance of prostheses made of the composite material. The present evaluation clarifies the in vivo performance of this new composite for orthopedic applications.